Xylem Inc. and Masco Corporation: A Detailed Examination of EBITDA Performance

EBITDA Growth: Xylem vs. Masco, 2014-2023

__timestampMasco CorporationXylem Inc.
Wednesday, January 1, 2014899000000631000000
Thursday, January 1, 20151041000000588000000
Friday, January 1, 20161220000000637000000
Sunday, January 1, 20171314000000814000000
Monday, January 1, 20181240000000948000000
Tuesday, January 1, 20191244000000947000000
Wednesday, January 1, 20201410000000736000000
Friday, January 1, 20211185000000853000000
Saturday, January 1, 20221490000000755000000
Sunday, January 1, 202314930000001150000000
Monday, January 1, 20241410000000
Loading chart...

Infusing magic into the data realm

A Comparative Analysis of EBITDA Growth: Xylem Inc. vs. Masco Corporation

In the ever-evolving landscape of industrial giants, Xylem Inc. and Masco Corporation have demonstrated intriguing EBITDA trajectories over the past decade. From 2014 to 2023, Masco Corporation's EBITDA surged by approximately 66%, peaking in 2023 with a remarkable 1.49 billion. Meanwhile, Xylem Inc. showcased a robust growth of nearly 83%, culminating in an impressive 1.15 billion in 2023.

Key Insights

  • 2014-2017: Masco consistently outperformed Xylem, with a notable 50% higher EBITDA in 2017.
  • 2018-2023: Xylem's strategic initiatives bore fruit, narrowing the gap significantly by 2023.

This analysis underscores the dynamic shifts in financial performance, reflecting strategic decisions and market conditions. As both companies continue to innovate, stakeholders and investors should keenly observe these trends for future opportunities.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
28 Jan 2025